14 - 15 June, 2012  — Directors' Roundtable
(Details are being shown below)

Scheduled Speakers 14 - 15 June, 2012

Strategy

The board’s role in the development of business strategy and challenges posed in volatile economic conditions and in rapidly changing business environment

  • Kelly Martin, Executive Director & CEO, Élan Corporation
  • Robert H. Flast, Author, No Excuses - A Business Process Approach to Managing Operational Risk; Management Consulting Partner, Computer Sciences Corp
  • Linda J. Welty, Director, Vertellus Specialties, Inc.; President and CEO, Welty Strategic Consulting, LLC

Risk Oversight

Evolving practices in setting the right risk appetite/profile and overseeing the processes for identifying and mitigating complex business risks

  • Alan L. Beller, Director, The Travelers Companies, Inc.; Partner, Cleary Gottlieb Steen & Hamilton LLP
  • Mary Ann Cloyd, Partner, PwC Center for Board Governance
  • Henry S. Miller, Director, American International Group, Inc.; Chairman, Marblegate Asset Management, LLC
  • Thomas J. Sabatino Jr., Director, Unigene Laboratories, Inc.; Executive Vice President – General Counsel, Corporate Secretary, Walgreens

The Outlook for MNCs in China

What Directors Need to Know – unique on-the-ground insight that you need to make informed and effective decisions about your business strategy in China

  • David Hoffman, Vice President & Managing Director, The Conference Board China Center for Economics and Business

CEO Oversight

Performance, Compensation and Succession how to assure the company has the right leader now and in the future and how high performing boards monitor and incentivize high CEO performance with long lasting results

  • Robert J. Jackson, Jr., Associate Professor of Law, Columbia Law School
  • Stephanie W. Abramson, Independent Director, National Financial Partners Corporation
  • James F. Reda, Founder & Managing Director, James F. Reda & Associates

Board Development

How boards assess board performance and effectiveness, recruit directors to optimize board effectiveness, address director turnover and the role of the lead director/independent chair

  • M. Faye Wilson, Independent Director, Biomed Realty Trust, Inc.; Director, Coronado First Bank
  • Julie Hembrock Daum, Co-lead, North American Board & CEO Practice, Spencer Stuart
  • Jeffrey D. Karpf, Partner, Cleary Gottlieb Steen & Hamilton LLP

Shareholder Engagement and Activism

The many faces of shareholder activism today

  • Ethan A. Klingsberg, Partner, Cleary Gottlieb Steen & Hamilton LLP
  • Donna F. Anderson, Vice President and Head of Global Corporate Governance,
    T. Rowe Price Group, Inc.
  • Edward P. Garden, Chief Investment Officer and Founding Partner, Trian Fund Management, L.P.; Director, Family Dollar, The Wendy’s Company

Shareholder Engagement and Activism

Successful models for shareholder engagement and the role of directors

  • Peggy Foran, Director, Occidental Petroleum Corporation; Chief Governance Officer & Corporate Secretary, Prudential Financial, Inc.
  • Bess Joffe, Vice President, Investor Relations, Goldman Sachs

Global Governance Trends

What trends globally are most likely to affect US companies in the near and intermediate term

  • Dan Konigsburg, Managing Director, Deloitte Center for Corporate Governance
  • Laurent Alpert, Director, Beazer Homes USA, Inc.; Partner, Cleary Gottlieb Steen & Hamilton LLP
  • Christoph A. Pereira, Chief Corporate, Securities & Finance Counsel, General Electric Company

Legal and Regulatory Update

2012 proxy season and other regulatory developments

  • Alan L. Beller, Director, The Travelers Companies, Inc.; Partner, Cleary Gottlieb Steen & Hamilton LLP
  • Robert B. Lamm, Assistant General Counsel and Assistant Secretary, Corporate Governance, Pfizer, Inc.
  • William Ultan, Senior Managing Director, Morrow & Co., LLC
Back to Top